创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Features of the ELISpot Platform

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-02-02 14:20
  • Views:

(Summary description)The InnoModels Biotechnology ELISpot platform provides researchers with a highly sensitive and specific method to accurately and rapidly analyze cell-secreted proteins, providing powerful support for research in immunology, oncology and other fields

InnoModels Biotechnology: Features of the ELISpot Platform

(Summary description)The InnoModels Biotechnology ELISpot platform provides researchers with a highly sensitive and specific method to accurately and rapidly analyze cell-secreted proteins, providing powerful support for research in immunology, oncology and other fields

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-02-02 14:20
  • Views:
Information

The InnoModels Biotechnology ELISpot platform provides researchers with a highly sensitive and specific method to accurately and rapidly analyze cell-secreted proteins, providing powerful support for research in immunology, oncology and other fields.
Technical features of ELISpot platform
1. High sensitivity and specificity:
The ELISpot platform tracks individual secreting cells by optical technology, realizing highly sensitive detection of tiny protein concentrations. Its highly specific detection method ensures accurate analysis of target molecules, providing researchers with a unique research advantage.
2. Single-cell analysis:
The ELISpot platform not only analyzes cell secretion at the population level, but also enables the analysis of individual cells. This feature enables researchers to gain a deeper understanding of the secretion heterogeneity among cell subpopulations, providing strong support for individualized treatment and research.
3. Multi-parameter analysis:
The ELISpot platform supports the simultaneous detection of multiple molecules secretion, through multi-parameter analysis, researchers can fully understand the expression level of different proteins, revealing the complexity of the cellular secretion network, which provides a powerful tool for in-depth study of the immune response.

 


4. Flexible experimental design:
ELISpot platform has flexible experimental design for different types of cells and secreted molecules. Researchers can choose different reagent kits according to their research needs and realize personalized experimental design to better meet their research needs.
5. Automatic data analysis and interpretation:
The ELISpot platform is equipped with advanced automated data analysis software, which enables researchers to quickly access, interpret and share experimental data. This feature reduces the difficulty of experimental operation, improves experimental efficiency, and allows researchers to focus on in-depth analysis of data.
Scientific Applications and Future Prospects
1. Immune monitoring and vaccine development:
The ELISpot platform is widely used in immunosurveillance and vaccine development, and can accurately assess cell-mediated immune responses, providing powerful support for vaccine efficacy evaluation and immunotherapy monitoring.
2. Tumor immunology research:
In tumor immunity research, ELISpot platform can reveal the secretion characteristics of immune cells in the tumor microenvironment, providing important information for the design and optimization of tumor immunotherapy.
3. autoimmune disease research:
The application of ELISpot platform in autoimmune disease research is expected to help researchers gain a deeper understanding of the mechanism of aberrant immune response, and provide new ideas for the development of therapies for related diseases.
Conclusion
With its excellent technical features, the ELISpot platform of InnoModels Biotechnology will surely become a leading tool in the field of cell secretion research. With its wide application in different research fields, the ELISpot platform will continue to promote the further development of scientific research and contribute to unlocking the mysteries of cell secretion potential.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司